Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.
| Stock | Insider | Value | Type | |||
|---|---|---|---|---|---|---|
| GPIGroup 1 Automotive Inc. | Conifer Management, L.L.C.10% Owner | $40.4M | Added | |||
| 26 tranches across Sept 3–4 at $278.18–$305.09; weighted avg ~$289.59. Now $281.60 (−2.8% since buy). Conifer's aggregate position reaches 1,362,640 shares. | ||||||
| UBERUber Technologies, Inc. | Andrew MacdonaldPresident and Chief Operating Officer | $5.31M | Added | |||
| Two tranches Sept 4: 54,325 at $75.65 and 15,675 at $76.44; weighted avg $75.85. Now $73.13 (−3.6% since buy). | ||||||
| SUJASuja Life, Inc. | Paine Schwartz Food Chain Fund V GP, Ltd.10% Owner | $3.13M | Added | |||
| Three tranches: 125K at $10.57 (Sept 3), 125K at $10.48 (Sept 4), 50K at $9.90 (Sept 8); avg $10.42. Now $9.89 (−5.1% since buy). Continued accumulation by institutional 10% owner. | ||||||
| INBXInhibrx Biosciences, Inc. | Mark P. LappeChief Executive Officer | $2.65M | Added | |||
| Six tranches Sept 8 at $99.29–$112.28; avg $105.81. Now $114.34 (+8.1% since buy). Part of three-insider cluster: CEO + 2 directors bought same day for combined ~$3.5M. | ||||||
| AMRAlpha Metallurgical Resources, Inc. | Courtis Kenneth S.Director | $2.26M | Added | |||
| Six tranches Sept 8 at $223.85–$229.39; avg $225.81. Now $223.74 (−0.9% since buy). Director now holds 1,035,394 shares. | ||||||
| EIKNEikon Therapeutics, Inc. | Peter Svennilson10% Owner | $1.03M | Added | |||
| Purchases Sept 3 at $11.17–$11.64; avg $11.56. Now $10.71 (−7.3% since buy). Bought via Column Group entities. 10% owner adding to large existing position. | ||||||
| INBXInhibrx Biosciences, Inc. | Jon Faiz KayyemDirector | $568K | Added | |||
| 5,000 shares Sept 8 at $113.30–$113.55; avg $113.52. Now $114.34 (+0.7% since buy). Via Kayyem family trust. Part of three-insider cluster at INBX. | ||||||
| GPUSHyperscale Data, Inc. | Milton C. Ault IIIExecutive Chairman | $362K | Added | |||
| 1,913,691 shares Sept 4 at $0.1889 (indirect via Ault & Company, Inc.); now $0.1879 (−0.5% since buy). Penny stock. Ault also bought 235,000 shares directly (<$250K threshold). | ||||||
| CMTGClaros Mortgage Trust, Inc. | Richard MackCEO and Chairman | $318K | Added | |||
| 200K shares Sept 3 at $1.5924 avg; now $1.54 (−3.3% since buy). CEO buying near multi-year lows in distressed mortgage REIT. Holds 3.1M shares post-transaction. | ||||||
| INBXInhibrx Biosciences, Inc. | Douglas G. ForsythDirector | $287K | Added | |||
| 2,500 shares Sept 8 at $114.36–$114.69; avg $114.65. Now $114.34 (−0.3% since buy). Via Forsyth Family Trust. Part of three-insider cluster at INBX. | ||||||
Scanned the last 24 hours of EDGAR Form 4 filings. 10 qualifying buys (≥ $250K, transaction type P) totalling $56.3M.
Dominant theme: Biotech & conviction cluster buying. Inhibrx Biosciences (INBX) stands out with three separate insiders purchasing on the same day (Sept 8) for a combined ~$3.5M — CEO plus two directors. Cluster buys of this kind are among the highest-conviction signals in Form 4 analysis. INBX's CEO Lappe bought at the lowest prices ($99–$112) while the two directors bought at higher levels ($113–$115), suggesting comfort across a range.
Auto sector: Conifer Management's $40.4M purchase of Group 1 Automotive (GPI) over two days is the standout by dollar size — a 10% owner continuing aggressive accumulation with the stock near $280–$305.
Energy/materials: Alpha Metallurgical Resources director Courtis put $2.3M to work in coal producer AMR — a sector facing macro headwinds but clearly supported by insiders.
Distressed REIT: Claros Mortgage Trust CEO Mack buying $318K at $1.59 is notable for a stock under $2 — management expressing confidence in a troubled mortgage REIT.
Hyperscale Data (GPUS): Milton Ault's penny-stock accumulation (~$362K indirect) continues a multi-quarter pattern; micro-cap, high risk.
Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.
SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →
See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.
Open the live chartOpen in the Stocks tab© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.